WPL Shares on issue 52% 963,580,000
Grasschoppa WPL valuation $31,000,000,000 equals $32.17 per share covid and merger adjusted.
New WPL shares to be issued to BHP holders 48% 889,458,461
Grasschoppa BHPP Valuation $15,000,000,000 equals $16.86 per share covid adjusted non merger adjusted (should be a positive here, unlike wpl holders have negative merger adjusted
Our new combined share value is 32.17+16.86/1.923 = $ 25.49566
Today we are trading at $ 20.73
* 1.923 is the ratio figure derived.... (963.580,000+889,458,461)/963,580,000
Watch out if you still want to be a WPL Holder
My guess is trading halt tomorrow!
- Forums
- ASX - By Stock
- WDS
- Ann: BHP: Response to press speculation on BHP Petroleum business
Ann: BHP: Response to press speculation on BHP Petroleum business, page-181
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
Add WDS (ASX) to my watchlist
|
|||||
Last
$28.94 |
Change
0.100(0.35%) |
Mkt cap ! $54.98B |
Open | High | Low | Value | Volume |
$29.20 | $29.26 | $28.86 | $116.0M | 4.000M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 17192 | $28.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$28.94 | 8356 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 16682 | 31.820 |
2 | 24401 | 31.220 |
1 | 3728 | 31.090 |
1 | 100 | 31.000 |
1 | 85593 | 30.950 |
Price($) | Vol. | No. |
---|---|---|
26.040 | 5043 | 1 |
26.900 | 288 | 1 |
26.910 | 1795 | 2 |
27.180 | 1 | 1 |
27.460 | 31908 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
WDS (ASX) Chart |